MedPath

Genus Lifesciences Inc.

Genus Lifesciences Inc. logo
🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

6

Active:0
Completed:6

Trial Phases

2 Phases

Phase 1:2
Not Applicable:2

Drug Approvals

14

FDA:14

Drug Approvals

FIDOQUEL-CA1

Approval Date
Mar 25, 2025
FDA

PHENOBARBITAL

Approval Date
Mar 3, 2025
FDA

Carbinoxamine Maleate

Approval Date
Mar 6, 2024
FDA

cocaine hydrochloride

Approval Date
Mar 4, 2024
FDA

Oxycodone Hydrochloride

Approval Date
Jan 12, 2024
FDA

Oxycodone Hydrochloride

Approval Date
Jan 12, 2024
FDA

Hydrocodone Bitartrate and Acetaminophen

Approval Date
Oct 18, 2023
FDA

Hydrocodone Bitartrate and Acetaminophen

Approval Date
Oct 11, 2023
FDA

Acetaminophen and Codeine Phosphate

Approval Date
Aug 16, 2023
FDA

GOPRELTO

Approval Date
Aug 8, 2023
FDA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (50.0%)
Phase 1
2 (50.0%)
No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath